| Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms IH Sahin, M Akce, O Alese, W Shaib, GB Lesinski, B El-Rayes, C Wu British journal of cancer 121 (10), 809-818, 2019 | 281 | 2019 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 234 | 2023 |
| The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced‐stage cancer treated with immunotherapy MA Bilen, DJ Martini, Y Liu, C Lewis, HH Collins, JM Shabto, M Akce, ... Cancer 125 (1), 127-134, 2019 | 130 | 2019 |
| The potential of CAR T cell therapy in pancreatic cancer M Akce, MY Zaidi, EK Waller, BF El-Rayes, GB Lesinski Frontiers in immunology 9, 2166, 2018 | 118 | 2018 |
| Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy MA Bilen, JM Shabto, DJ Martini, Y Liu, C Lewis, H Collins, M Akce, ... Bmc Cancer 19, 1-8, 2019 | 105 | 2019 |
| Combined effect of sarcopenia and systemic inflammation on survival in patients with advanced stage cancer treated with immunotherapy MA Bilen, DJ Martini, Y Liu, JM Shabto, JT Brown, M Williams, AI Khan, ... The oncologist 25 (3), e528-e535, 2020 | 60 | 2020 |
| Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials DJ Martini, MR Kline, Y Liu, JM Shabto, MA Williams, AI Khan, C Lewis, ... Cancer 126 (3), 575-582, 2020 | 57 | 2020 |
| High‐grade gastrointestinal neuroendocrine carcinoma management and outcomes: A national cancer database study OB Alese, R Jiang, W Shaib, C Wu, M Akce, M Behera, BF El‐Rayes The oncologist 24 (7), 911-920, 2019 | 51 | 2019 |
| Impact of sarcopenia, BMI, and inflammatory biomarkers on survival in advanced hepatocellular carcinoma treated with anti-PD-1 antibody M Akce, Y Liu, K Zakka, DJ Martini, A Draper, OB Alese, WL Shaib, C Wu, ... American Journal of Clinical Oncology 44 (2), 74-81, 2021 | 47 | 2021 |
| Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial JM Llovet, M Kudo, P Merle, T Meyer, S Qin, M Ikeda, R Xu, J Edeline, ... The Lancet Oncology 24 (12), 1399-1410, 2023 | 46 | 2023 |
| Blood-based next-generation sequencing analysis of neuroendocrine neoplasms K Zakka, R Nagy, L Drusbosky, M Akce, C Wu, OB Alese, BF El-Rayes, ... Oncotarget 11 (19), 1749, 2020 | 42 | 2020 |
| Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis M Akce, R Jiang, OB Alese, WL Shaib, C Wu, M Behera, BF El-Rayes Journal of gastrointestinal oncology 10 (1), 85, 2019 | 39 | 2019 |
| CA209-9DX: phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative … MJJ Exposito, M Akce, JLM Alvarez, E Assenat, LA Balart, AD Baron, ... Annals of Oncology 29, viii267-viii268, 2018 | 37* | 2018 |
| Analysis of racial disparities in the treatment and outcomes of colorectal cancer in young adults OB Alese, R Jiang, KM Zakka, C Wu, W Shaib, M Akce, M Behera, ... Cancer Epidemiology 63, 101618, 2019 | 31 | 2019 |
| Evolving role of immunotherapy in advanced biliary tract cancers S Kang, BF El-Rayes, M Akce Cancers 14 (7), 1748, 2022 | 26 | 2022 |
| Clinical outcomes of small bowel adenocarcinoma M Akce, R Jiang, K Zakka, C Wu, OB Alese, WL Shaib, M Behera, ... Clinical Colorectal Cancer 18 (4), 257-268, 2019 | 25 | 2019 |
| NEO-GAP: A phase II single-arm prospective feasibility study of neoadjuvant gemcitabine/cisplatin/nab-paclitaxel for resectable high-risk intrahepatic cholangiocarcinoma. SK Maithel, MM Javle, A Mahipal, BSL Lin, M Akce, JM Switchenko, ... Journal of Clinical Oncology 40 (16_suppl), 4097-4097, 2022 | 21 | 2022 |
| Nonsurgical management of rectal cancer M Akce, BF El-Rayes Journal of Oncology Practice 15 (3), 123-131, 2019 | 21 | 2019 |
| Frontline therapy for advanced hepatocellular carcinoma: an update M Akce, BF El-Rayes, TS Bekaii-Saab Therapeutic Advances in Gastroenterology 15, 17562848221086126, 2022 | 19 | 2022 |
| Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma K Zakka, R Jiang, OB Alese, WL Shaib, C Wu, JP Wedd, MT Sellers, ... Journal of hepatocellular carcinoma, 119-129, 2019 | 19 | 2019 |
Sarah TempleBaylor College of Medicine, VA, UHCLVerified email at bcm.edu
